These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7092487)

  • 41. Mania associated with fluoxetine treatment in adolescents.
    Venkataraman S; Naylor MW; King CA
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):276-81. PubMed ID: 1564030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abuse of monoamine oxidase inhibitors.
    Baumbacher G; Hansen MS
    Am J Drug Alcohol Abuse; 1992; 18(4):399-406. PubMed ID: 1449122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypomania and mania after withdrawal of tricyclic antidepressants.
    Mirin SM; Schatzberg AF; Creasey DE
    Am J Psychiatry; 1981 Jan; 138(1):87-9. PubMed ID: 7446789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevation of plasma-prolactin by monoamine-oxidase inhibitors.
    Slater SL; Lipper S; Shiling DJ; Murphy DL
    Lancet; 1977 Aug; 2(8032):275-6. PubMed ID: 69882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    Teusink JP; Alexopoulos GS; Shamoian CA
    Am J Psychiatry; 1984 Jan; 141(1):118-9. PubMed ID: 6691428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of monoamine oxidase inhibitor-induced hypomania.
    Cohen R; Pickar D
    Arch Gen Psychiatry; 1978 Nov; 35(11):1393-4. PubMed ID: 708198
    [No Abstract]   [Full Text] [Related]  

  • 52. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Transition from the depressive stage to the manic stage during the treatment with antidepressive drugs].
    Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):76-82. PubMed ID: 1821982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological relationships between mania and melancholia.
    Post RM; Uhde TW
    Encephale; 1982; 8(2):213-28. PubMed ID: 6179764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction.
    Dănilă MD; Privistirescu AI; Mirica SN; Sturza A; Ordodi V; Noveanu L; Duicu OM; Muntean DM
    Can J Physiol Pharmacol; 2015 Sep; 93(9):819-25. PubMed ID: 26322912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of selective and non-selective monoamine oxidase (MAO) inhibitors on conflict behavior in the rat.
    Commissaris RL; Humrich J; Johns J; Geere DG; Fontana DJ
    Behav Pharmacol; 1995 Mar; 6(2):195-202. PubMed ID: 11224327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypomania after desipramine withdrawal.
    Nelson JC; Schottenfeld RS; Conrad CD
    Am J Psychiatry; 1983 May; 140(5):624-5. PubMed ID: 6846597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.